Alliance Global Partners Weighs in on Tilray FY2025 Earnings

Tilray Inc (NASDAQ:TLRY - Free Report) - Alliance Global Partners dropped their FY2025 earnings estimates for Tilray in a report released on Wednesday, April 9th. Alliance Global Partners analyst A. Grey now expects that the company will earn ($1.02) per share for the year, down from their previous estimate of ($0.18). The consensus estimate for Tilray's current full-year earnings is ($0.20) per share.

A number of other equities research analysts have also weighed in on the stock. Canaccord Genuity Group lifted their target price on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Piper Sandler cut their price objective on Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th.

Tilray Trading Down 2.9 %

NASDAQ:TLRY traded down $0.01 during trading hours on Monday, hitting $0.47. The company had a trading volume of 19,748,438 shares, compared to its average volume of 29,423,446. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The stock has a 50-day moving average price of $0.71 and a 200 day moving average price of $1.16. The company has a market capitalization of $443.32 million, a PE ratio of -1.58 and a beta of 1.88. Tilray has a 52 week low of $0.44 and a 52 week high of $2.52.

Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The business had revenue of $185.78 million during the quarter, compared to the consensus estimate of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%.

Remove Ads

Institutional Investors Weigh In On Tilray

Several hedge funds have recently bought and sold shares of the business. Tidal Investments LLC grew its stake in shares of Tilray by 9.2% in the 4th quarter. Tidal Investments LLC now owns 10,595,264 shares of the company's stock worth $14,092,000 after buying an additional 889,086 shares during the last quarter. Quinn Opportunity Partners LLC grew its stake in shares of Tilray by 108.0% in the fourth quarter. Quinn Opportunity Partners LLC now owns 1,618,080 shares of the company's stock worth $2,152,000 after acquiring an additional 840,000 shares during the last quarter. Virtu Financial LLC bought a new position in shares of Tilray during the fourth quarter valued at $1,029,000. Dimensional Fund Advisors LP raised its position in shares of Tilray by 54.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company's stock worth $2,890,000 after purchasing an additional 769,569 shares during the last quarter. Finally, Millennium Management LLC bought a new position in Tilray in the 4th quarter worth about $879,000. Institutional investors own 9.35% of the company's stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.